Lonnel Coats - Feb 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Lonnel Coats
Stock symbol
LXRX
Transactions as of
Feb 28, 2024
Transactions value $
-$160,792
Form type
4
Date filed
2/29/2024, 04:26 PM
Previous filing
Feb 12, 2024
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +33.3K +3.65% 948K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +91.4K +9.64% 1.04M Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +120K +11.59% 1.16M Feb 28, 2024 Direct F1
transaction LXRX Common Stock Tax liability -$161K -61.4K -5.29% $2.62 1.1M Feb 28, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -33.3K -100% 0 Feb 28, 2024 Common Stock 33.3K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -91.4K -50% 91.4K Feb 28, 2024 Common Stock 91.4K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -120K -33.33% 241K Feb 28, 2024 Common Stock 120K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.